Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Kempharm Inc
(NQ:
KMPH
)
5.810
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Kempharm Inc
< Previous
1
2
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
May 13, 2021
Gainers Bionano Genomics (NASDAQ:BNGO) st...
Via
Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
April 28, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
6 Stocks Moving In Wednesday's After-Hours Session
April 21, 2021
Gainers Teradata (NYSE: TDC) shares are trading higher after the company announced it raised Q1 EPS guidance above estimates. Kinder Morgan (NYSE: KMI) shares are trading higher...
Via
Benzinga
10 Biggest Price Target Changes For Friday
April 09, 2021
Credit Suisse raised the price target on Carnival Corporation (NYSE: CCL) from $18 to $40. Carnival shares rose 1.2% to $28.89 in pre-market trading. Barclays boosted the price...
Via
Benzinga
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
April 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...
Via
Benzinga
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
April 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc...
Via
Benzinga
KemPharm Amends Licensing Agreement With Gurnet Point Capital, Increases Milestone Payments To $590M
April 09, 2021
KemPharm Inc (NASDAQ: KMPH) has amended the collaboration and license agreement with Gurnet Point Capital (GPC), a private investment firm. The...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 08, 2021
Gainers DiaMedica Therapeutics (NASDAQ:DMAC) shares increased by 6.17% to $9.98 during Thursday's after-market session. DiaMedica Therapeutics's trading volume hit 12.0K...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.